Skip to content

Growth hormone axis

IGF-1 LR3

Also called Long R3 IGF-1

InjectableEvidence CEvery day
Half-life
20hours
Typical vial
1mg
Research amounts
20–50mcg

per administration

Common schedule
Every day
Animal or lab only

Only animal or lab studies exist — no human study has set an amount.

Work out your draw

These numbers are a starting point — change any of them.

3 mL cartridge · 300 units loaded6units dialled
Concentration
0.33mg/mL
Volume per draw
0.06mL
Units to dial
6
Doses per cartridge
50

Vial label

Copy this into your label printer.

Published research contexts for IGF-1 LR3 describe 2050 mcg per administration. Descriptive only, not a recommendation.

Community figures put it far longer than native IGF-1 because it binds IGF-binding proteins weakly; human pharmacokinetics are not established.

An IGF-1 analog sold mainly as a cell-culture reagent; no human dose-ranging study fixes an injected amount or schedule, so no schedule table is shown.

Modelled level — every day

1× is the peak after a single dose.

Steady-state peak
1.77× single dose

Read off the modelled curve, not an even-interval formula

Time to steady state
4.2days

About five half-lives

Administrations
7/ week

Where these numbers come from

  • Long R3 IGF-1 laboratory-reagent literatureAn IGF-1 analog with weak IGF-binding-protein affinity, sold mainly as a cell-culture reagent; human injected amounts are community-derived.

Next steps